Polaris Regulatory

Strategic
clarity for
Complex
problems.

We help organisations navigate regulatory complexity, build operational capability, and make better decisions at every stage of growth.

Start a conversation
Module 3 Authoring MAA/BLA Submissions IND Filings Scientific Advice Health Authority Interactions Post-Approval Variations GMP Compliance Analytical Control Strategy / Method Validation Module 3 Authoring MAA/BLA Submissions IND Filings Scientific Advice Health Authority Interactions Post-Approval Variations GMP Compliance Analytical Control Strategy / Method Validation
About

Deep expertise, Practical outcomes.

Polaris Regulatory provides strategic Regulatory CMC support to biotech and pharmaceutical companies developing complex medicines. We help clients navigate CMC strategy, regulatory submissions, agency interactions, development risk, and lifecycle management with clarity, pragmatism, and scientific understanding. Our focus is on turning complex CMC challenges into clear regulatory pathways, helping development teams make better decisions, prepare stronger submissions, and move medicines forward with confidence.

Daniel
Kavanagh

Daniel is the founder and managing director of Polaris Regulatory, bringing over 15 years of hands-on experience in regulatory affairs CMC across the pharmaceutical and biotech sectors. Having worked with organisations ranging from early-stage startups to global multinationals, he brings a perspective that is both technically rigorous and commercially grounded.

Prior to founding Polaris, he held senior roles in consulting and industry, where he led CMC strategy and submissions, built regulatory teams from the ground up, and guided products through complex approval pathways across Europe, the United States and beyond.

Daniel Kavanagh

Founder & Managing Director

dkavanagh@polarisregulatory.com Daniel Kavanagh
Services

How we can help

Polaris Regulatory offers focused, expert-led consulting across the full regulatory lifecycle. Whether you are preparing your first submission, managing a complex portfolio, or building the internal capability to scale — we bring the depth of experience and the clarity of purpose to move your programme forward.

01

Module 3 Authoring & Submissions

Expert preparation and review of CMC dossiers for MAA, BLA, IND, and variation submissions. We write, review, and coordinate Module 3 content to the highest regulatory standard across EU and US markets.

Module 3 MAA/BLA IND Filings Post-Approval Variations
02

CMC Development Strategy

Strategic guidance across the full CMC development lifecycle, from drug substance and drug product development through process validation, analytical method validation, stability strategy, and GMP compliance.

Process Validation Analytical Methods Stability Strategy GMP Compliance
03

Capability & Team Development

Building internal regulatory functions that scale. Training, process design, and strategic workshops for high-growth organisations.

Workshops Team Building Process Design
Our Values

We are Innovative

We bring fresh thinking to every engagement. Regulatory science evolves, so do we. We actively seek better approaches, challenge convention, and bring creative solutions to Complex problems.

We are Entrepreneurial

We think and act like owners. We are invested in the outcomes of our clients' programmes and bring the same drive, resourcefulness, and commitment we would apply to our own ventures.

We are Humble

We listen before we advise. The best outcomes come from genuine collaboration and an honest acknowledgement of what we know, what we don't, and what we can find out.

We are Agile

Regulatory landscapes shift quickly. We move with them, adapting our approach, our priorities, and our thinking to meet the needs of each client at each stage of their journey.

We are People First

Relationships are the foundation of everything we do, and people are at the heart of it all. We build relationships — with clients, with agencies, and within our own team — grounded in trust, respect, and a genuine interest in each other's success. Ultimately, to get life changing and life saving medications in the hands of the patients who need them.

Insights & perspectives

Subscribe for updates

Practical thinking on CMC science, regulatory strategy, and building high-performing teams in biopharma. Written by Daniel Kavanagh, drawing on real experience across drug development and regulatory submissions.

Analytical CMC Daniel Kavanagh

Discriminatory Power: The Make or Break Factor in Dissolution Methods

Dissolution testing is one of the most widely used tools in drug product development, but not all methods are created equal. This article explores why discriminatory power is the critical factor that determines whether your dissolution method is truly fit for purpose.

Read on LinkedIn ↗
Biologics · CMC Daniel Kavanagh

Where Should Bioburden Filtration Occur in a mAb Purification Train?

Placement of bioburden reduction filtration in a monoclonal antibody purification process is a decision with significant downstream implications. This article examines the key considerations and how to make the right call for your process.

Read on LinkedIn ↗
CMC Strategy Daniel Kavanagh

Why Clarity Is the Most Underrated CMC Skill

Technical expertise is essential in CMC, but it is rarely the thing that makes or breaks a regulatory submission. This article makes the case for clarity of communication as the skill that separates good regulatory scientists from great ones.

Read on LinkedIn ↗
Regulatory Leadership Daniel Kavanagh

The Future of Regulatory Leadership in Biopharma

The role of the regulatory leader is evolving rapidly. As pipelines grow more complex and the pace of innovation accelerates, what does it take to lead a regulatory function that is truly fit for the future?

Read on LinkedIn ↗
Team & Leadership Daniel Kavanagh

Scaling Teams in Biotech — Lessons Learned

Growing a regulatory team in a fast-moving biotech environment is one of the most challenging and rewarding things a leader can do. This article shares honest lessons from the experience of building and scaling teams under pressure.

Read on LinkedIn ↗

Let's work
together

Whether you are facing an immediate regulatory challenge, planning a submission, or thinking about how to build long-term capability within your organisation, we would welcome a conversation.

Engagements typically begin with a short introductory call to understand your situation. From there, we will propose a scope that fits your timeline and budget. There is no obligation and no charge for the initial conversation.

Email info@polarisregulatory.com ↗ LinkedIn Polaris Regulatory on LinkedIn ↗